|
1
|
Wu G, Wang X, Wang X, Jiang H, Wang L,
Wang T, Liu J, An D, Cao L, Xia Y and Zong G: Serum parathyroid
hormone levels predict discharge and readmission for heart failure.
Genet Test Mol Biomarkers. 20:328–334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Altay H and Colkesen Y: Parathyroid
hormone and heart failure: Novel biomarker strategy. Endocr Metab
Immune Disord Drug Targets. 13:100–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kubiak GM, Kolaszko A and
Nowalany-Kozielska E: Parathyroid hormone serum concentration in
Central European patients with non-ischemic heart failure as a
potential marker of disease severity and poor prognosis. Endokrynol
Pol. 68:299–305. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ballane GT, Sfeir JG, Dakik HA, Brown EM
and El-Hajj Fuleihan G: Use of recombinant human parathyroid
hormone in hypocalcemic cardiomyopathy. Eur J Endocrinol.
166:1113–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qian J, Colbert MC, Witte D, Kuan CY,
Gruenstein E, Osinka H, Lanske B, Kronenberg HM and Clemens TL:
Midgestational lethality in mice lacking the Parathyroid hormone
(PTH)/PTH-related peptide receptor is associated with abrupt
cardiomyocyte death. Endocrinology. 144:1053–1061. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Monego G, Arena V, Pasquini S, Stigliano
E, Fiaccavento R, Leone O, Arpesella G, Potena L, Ranelletti FO, Di
Nardo P and Capelli A: Ischemic injury activates PTHrP and PTH1R
expression in human ventricular cardiomyocytes. Basic Res Cardiol.
104:427–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zittermann A, Ernst JB, Pilz S, Dreier J,
Kuhn J, Knabbe C, Gummert JF, Morshuis M and Milting H:
Calciotropic and phosphaturic hormones in end-stage heart failure
patients supported by a left-ventricular assist device. PLoS One.
11:e01644592016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi YH, Cowan DB, Wahlers TC, Hetzer R,
Del Nido PJ and Stamm C: Calcium sensitisation impairs diastolic
relaxation in post-ischaemic myocardium: Implications for the use
of Ca(2+) sensitising inotropes after cardiac surgery. Eur J
Cardiothorac Surg. 37:376–383. 2010.PubMed/NCBI
|
|
9
|
Osto E, Fallo F, Pelizzo MR, Maddalozzo A,
Sorgato N, Corbetti F, Montisci R, Famoso G, Bellu R, Lüscher TF,
et al: Coronary microvascular dysfunction induced by primary
hyperparathyroidism is restored after parathyroidectomy.
Circulation. 126:1031–1039. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Capitanio S, Sambuceti G, Giusti M,
Morbelli S, Murialdo G, Garibotto G, Vera L, Ameri P, Repetto B,
Naseri M, et al: 1,25-Dihydroxy vitamin D and coronary
microvascular function. Eur J Nucl Med Mol Imaging. 40:280–289.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Verdoia M, Pergolini P, Rolla R, Nardin M,
Barbieri L, Schaffer A, Bellomo G, Marino P, Suryapranata H and De
Luca G: Novara Atherosclerosis Study Group (NAS): Parathyroid
hormone levels and high-residual platelet reactivity in patients
receiving dual antiplatelet therapy with acetylsalicylic acid and
clopidogrel or ticagrelor. Cardiovasc Ther. 34:209–215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schreckenberg R, Wenzel S, da Costa Rebelo
RM, Röthig A, Meyer R and Schlüter KD: Cell-specific effects of
nitric oxide deficiency on parathyroid hormone-related peptide
(PTHrP) responsiveness and PTH1 receptor expression in
cardiovascular cells. Endocrinology. 150:3735–3741. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang LL, Chen D, Lee J, Gu X, Alaaeddine
G, Li J, Wei L and Yu SP: Mobilization of endogenous bone marrow
derived endothelial progenitor cells and therapeutic potential of
parathyroid hormone after ischemic stroke in mice. PLoS One.
9:e872842014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang ST, Gao YJ, Duan CC, Li DD, Tian XC,
Zhang QL, Guo B and Yue ZP: Effects of PTHrP on expression of MMP9
and MMP13 in sika deer antler chondrocytes. Cell Biol Int.
37:1300–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li S, Zou D, Li C, Meng H, Sui W, Feng S,
Cheng T, Zhai Q and Qiu L: Targeting stem cell niche can protect
hematopoietic stem cells from chemotherapy and G-CSF treatment.
Stem Cell Res Ther. 6:1752015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cusano NE, Rubin MR, Zhang C, Anderson L,
Levy E, Costa AG, Irani D and Bilezikian JP: Parathyroid hormone
1–84 alters circulating vascular endothelial growth factor levels
in hypoparathyroidism. J Clin Endocrinol Metab. 99:E2025–E2028.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Engelmann MG, Theiss HD, Hennig-Theiss C,
Huber A, Wintersperger BJ, Werle-Ruedinger AE, Schoenberg SO,
Steinbeck G and Franz WM: Autologous bone marrow stem cell
mobilization induced by granulocyte colony-stimulating factor after
subacute ST-segment elevation myocardial infarction undergoing late
revascularization: Final results from the G-CSF-STEMI (Granulocyte
Colony-Stimulating Factor ST-Segment Elevation Myocardial
Infarction) trial. J Am Coll Cardiol. 48:1712–1721. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zohlnhöfer D, Ott I, Mehilli J, Schömig K,
Michalk F, Ibrahim T, Meisetschläger G, von Wedel J, Bollwein H,
Seyfarth M, et al: Stem cell mobilization by granulocyte
colony-stimulating factor in patients with acute myocardial
infarction: A randomized controlled trial. JAMA. 295:1003–1010.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zaruba MM, Huber BC, Brunner S, Deindl E,
David R, Fischer R, Assmann G, Herbach N, Grundmann S, Wanke R, et
al: Parathyroid hormone treatment after myocardial infarction
promotes cardiac repair by enhanced neovascularization and cell
survival. Cardiovasc Res. 77:722–731. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brunner S, Weinberger T, Huber BC, Segeth
A, Zaruba MM, Theiss HD, Assmann G, Herbach N, Wanke R,
Mueller-Hoecker J and Franz WM: The cardioprotective effects of
parathyroid hormone are independent of endogenous
granulocyte-colony stimulating factor release. Cardiovasc Res.
93:330–339. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teraoka K, Hirano M, Yamaguchi K and
Yamashina A: Progressive cardiac dysfunction in adriamycin-induced
cardiomyopathy rats. Eur J Heart Fail. 2:373–378. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schlüter KD and Piper HM: Cardiovascular
actions of parathyroid hormone and parathyroid hormone-related
peptide. Cardiovasc Res. 37:34–41. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noda M, Katoh T, Takuwa N, Kumada M,
Kurokawa K and Takuwa Y: Synergistic stimulation of parathyroid
hormone-related peptide gene expression by mechanical stretch and
angiotensin II in rat aortic smooth muscle cells. J Biol Chem.
269:17911–17917. 1994.PubMed/NCBI
|
|
24
|
Wu P, Xie F, Xue M, Xu X, He S, Lin M and
Bai L: Advanced oxidation protein products decrease the expression
of calcium transport channels in small intestinal epithelium via
the p44/42 MAPK signaling pathway. Eur J Cell Biol. 94:190–203.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Selim AA, Mahon M, Juppner H, Bringhurst
FR and Divieti P: Role of calcium channels in carboxyl-terminal
parathyroid hormone receptor signaling. Am J Physiol Cell Physiol.
291:C114–C121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hagström E, Ahlström T, Ärnlöv J, Larsson
A, Melhus H, Hellman P and Lind L: Parathyroid hormone and calcium
are independently associated with subclinical vascular disease in a
community-based cohort. Atherosclerosis. 238:420–426. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rocha-Singh KJ, Zeller T and Jaff MR:
Peripheral arterial calcification: Prevalence, mechanism,
detection, and clinical implications. Catheter Cardiovasc Interv.
83:E212–E220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seeland U, Selejan S, Engelhardt S, Müller
P, Lohse MJ and Böhm M: Interstitial remodeling in beta1-adrenergic
receptor transgenic mice. Basic Res Cardiol. 102:183–193. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong ZR, Gil HW, Yang JO, Lee EY, Ahn JO
and Hong SY: Associations between sympathetic activity, plasma
concentrations of renin, aldosterone, and parathyroid hormone, and
the degree of intractability of blood pressure control in
modialysis patients. J Korean Med Sci. 22:604–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng ZY, Ye T, Ling QY, Wu T, Wu GY and
Zong GJ: Parathyroid hormone promotes osteoblastic differentiation
of endothelial cells via the extracellular signal-regulated protein
kinase 1/2 and nuclear factor-κB signaling pathways. Exp Ther Med.
15:1754–1760. 2018.PubMed/NCBI
|
